AIMS: The main objective of this study was to determine the sensitivity of abdominal ultrasonography (US) in patients with isoattenuating pancreatic carcinoma and to compare the frequency of secondary signs on abdominal US and endoscopic ultrasonography (EUS) in these tumours. METHODS: Twenty-four patients with histologically or cytologically verified isoattenuating pancreatic carcinoma who underwent abdominal US, contrast-enhanced CT and EUS of the pancreas as part of the diagnostic workup were included in this retrospective study. The sensitivity of abdominal US in detecting the isoattenuating pancreatic carcinoma was investigated and the frequency of secondary signs of isoattenuating pancreatic carcinoma on abdominal US and EUS was compared. RESULTS: In 5 of 24 patients (21%) with isoattenuating pancreatic carcinoma, a hypoechogenic pancreatic lesion was directly visualised on abdominal US. Secondary signs were present on US in 21 patients (88%). These included dilatation of the common bile duct and/or intrahepatic bile ducts in 19/24 (79%), dilatation of the pancreatic duct in 3/24 (13%), abnormal contour/inhomogeneity of the pancreas in 1/24 (4%), and atrophy of the distal parenchyma in 1/24 (4%). Pancreatic duct dilatation was observed more frequently on EUS than on abdominal US (P=0.002). For other secondary signs, there was no significant difference in their detection on abdominal US and EUS (P=0.61-1.00). CONCLUSION: Abdominal US is capable of detecting secondary signs of isoattenuating pancreatic carcinoma with high sensitivity and has the potential to directly visualise these tumours.

2nd Department of Internal Medicine Gastroenterology and Geriatrics Faculty of Medicine and Dentistry Palacky University Olomouc and University Hospital Olomouc Czech Republic

AGEL Research and Training Institute Prostejov Czech Republic

Department of Radiology and Nuclear Medicine University Hospital Brno and Masaryk University Brno Brno Czech Republic

Department of Radiology University Hospital Olomouc and Faculty of Medicine and Dentistry Palacky University Olomouc Czech Republic

Department of Radiology Vitkovice Hospital Ostrava Czech Republic

Digestive Diseases Center Vitkovice Hospital Ostrava Czech Republic

Institute of Endocrinology Prague Czech Republic

Zobrazit více v PubMed

Pehalova L, Krejci D, Snajdrova L, Dusek L. Cancer incidence trends in the Czech Republic. Cancer Epidemiol 2021;74:101975. DOI

Dušek L, Mužík J, Koptíková M, Žaloudík J, Vyzula R. Epidemiologie zhoubných nádorů v České republice. Masarykova univerzita [Internet]. 2005 [cited 2022 Jan 24];(Version 7.0 [2007]). Available from: https://svod.cz/ (In Czech)

Ashida R, Tanaka S, Yamanaka H, Okagaki S, Nakao K, Fukuda J, Nakao M, Ioka T, Katayama K. The Role of Transabdominal Ultrasound in the Diagnosis of Early Stage Pancreatic Cancer: Review and Single-Center Experience. Diagnostics 2018;9(1):2. DOI

Vaněk P, Zoundjiekpon V, Slodička P, Tichý T, Tesaříková J, Švébišová H, Kovář R, Kurfürstová D, Janíková M, Woitková V, Procházka M, Falt P, Urban O. Pancreatic cancer screening: ready for prime time? Gastroenterol Hepatol 2021;75(5):390-8. DOI

Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Gastroenterology 2018;155(3):740-51.e2. DOI

Roalsø M, Aunan JR, Søreide K. Refined TNM-staging for pancreatic adenocarcinoma - Real progress or much ado about nothing? Eur J Surg Oncol 2020;46(8):1554-7. DOI

Yoon SH, Lee JM, Cho JY, Lee KB, Kim JE, Moon SK, Kim SJ, Baek JH, Kim SH, Kim SH, Lee JY, Han JK, Choi BI. Small (le;20 mm) Pancreatic Adenocarcinomas: Analysis of Enhancement Patterns and Secondary Signs with Multiphasic Multidetector CT. Radiology 2011;259(2):442-52. DOI

Kim JH, Park SH, Yu ES, Kim M-H, Kim J, Byun JH, Lee SS, Hwang HJ, Hwang J-Y, Lee SS, Lee M-G. Visually Isoattenuating Pancreatic Adenocarcinoma at Dynamic-Enhanced CT: Frequency, Clinical and Pathologic Characteristics, and Diagnosis at Imaging Examinations. Radiology 2010;257(1):87-96. DOI

Psar R, Urban O, Cerna M, Rohan T, Hill M. Improvement of the Diagnosis of Isoattenuating Pancreatic Carcinomas by Defining Their Characteristics on Contrast Enhanced Computed Tomography and Endosonography with Fine-Needle Aspiration (EUS-FNA). Diagnostics 2021;11(5):776. DOI

Blouhos K, Boulas KA, Tsalis K, Hatzigeorgiadis A. The isoattenuating pancreatic adenocarcinoma: Review of the literature and critical analysis. Surg Oncol 2015;24(4):322-8. DOI

Brunner M, Wu Z, Krautz C, Pilarsky C, Grützmann R, Weber GF. Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions. Int J Mol Sci 2019;20(18):4543. DOI

Kunovsky L, Tesarikova P, Kala Z, Kroupa R, Kysela P, Dolina J, Trna J. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer. Can J Gastroenterol Hepatol 2018;2018:1-10. DOI

Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB. Isoattenuating Pancreatic Adenocarcinoma at Multi-Detector Row CT: Secondary Signs. Radiology 2002;224(3):764-8. DOI

Ishigami K, Yoshimitsu K, Irie H, Tajima T, Asayama Y, Nishie A, Hirakawa M, Ushijima Y, Okamoto D, Nagata S, Nishihara Y, Yamaguchi K, Taketomi A, Honda H. Diagnostic value of the delayed phase image for iso-attenuating pancreatic carcinomas in the pancreatic parenchymal phase on multidetector computed tomography. Eur J Radiol 2009;69(1):139-46. DOI

Tamada T, Ito K, Kanomata N, Sone T, Kanki A, Higaki A, Hayashida M, Yamamoto A. Pancreatic adenocarcinomas without secondary signs on multiphasic multidetector CT: association with clinical and histopathologic features. Eur Radiol 2016;26(3):646-55. DOI

Aslan S, Nural MS, Camlidag I, Danaci M. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions. Abdom Radiol 2019;44(2):593-603. DOI

Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: A state-of-the-art review. World J Gastroenterol 2014;20(24):7864-77. DOI

Psar R, Urban O, Cerna M, Psarova V. Visualisation of pancreatic adenocarcinoma and its differential diagnosis using imaging methods. Ces Radiol 2019;73(2):118-24.

Zhang L, Sanagapalli S, Stoita A. Challenges in diagnosis of pancreatic cancer. World J Gastroenterol 2018;24(19):2047-60. DOI

Trna J, Kala Z, Kunovsky L, a kol. Klinická pankreatologie. 2.přepracované a doplněné vydání. Praha: Maxdorf; 2021. (In Czech)

Okaniwa S. How Does Ultrasound Manage Pancreatic Diseases? Ultrasound Findings and Scanning Maneuvers. Gut Liver 2020;14(1):37-46. DOI

Choi S-Y, Kim JH, Eun HW, Ryu H. Factors affecting the ability of abdominal ultrasonography to detect focal pancreatic lesions identified using endoscopic ultrasonography. Ultrasonography 2020;39(3):247-56. DOI

Kanno A, Masamune A, Hanada K, Maguchi H, Shimizu Y, Ueki T, Hasebe O, Ohtsuka T, Nakamura M, Takenaka M, Kitano M, Kikuyama M, Gabata T, Yoshida K, Sasaki T, Serikawa M, Furukawa T, Yanagisawa A, Shimosegawa T. Multicenter study of early pancreatic cancer in Japan. Pancreatology 2018;18(1):61-7. DOI

Low G, Panu A, Millo N, Leen E. Multimodality Imaging of Neoplastic and Nonneoplastic Solid Lesions of the Pancreas. Radiographics 2011;31(4):993-1015. DOI

Rajan E, Clain JE, Levy MJ, Norton ID, Wang KK, Wiersema MJ, Vazquez-Sequeiros E, Nelson BJ, Jondal ML, Kendall RK, Harmsen WS, Zinsmeister AR. Age-related changes in the pancreas identified by EUS: a prospective evaluation. Gastrointest Endosc 2005;61(3):401-6. DOI

Iiboshi T, Hanada K, Fukuda T, Yonehara S, Sasaki T, Chayama K. Value of Cytodiagnosis Using Endoscopic Nasopancreatic Drainage for Early Diagnosis of Pancreatic Cancer: Establishing a New Method for the Early Detection of Pancreatic Carcinoma In Situ. Pancreas 2012;41(4):523-9. DOI